BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27414468)

  • 1. Synthesis of novel disulfide and sulfone hybrid scaffolds as potent β-glucuronidase inhibitor.
    Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Al Muqarrabin LM; Zaki HM; Ahmat N; Nasir A; Khan F
    Bioorg Chem; 2016 Oct; 68():15-22. PubMed ID: 27414468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, β-glucuronidase inhibition and molecular docking studies of hybrid bisindole-thiosemicarbazides analogs.
    Taha M; Ismail NH; Imran S; Rahim F; Wadood A; Khan H; Ullah H; Salar U; Khan KM
    Bioorg Chem; 2016 Oct; 68():56-63. PubMed ID: 27454618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of bis-indolylmethanes as new potential inhibitors of β-glucuronidase and their molecular docking studies.
    Taha M; Ullah H; Al Muqarrabun LMR; Khan MN; Rahim F; Ahmat N; Ali M; Perveen S
    Eur J Med Chem; 2018 Jan; 143():1757-1767. PubMed ID: 29133042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis: Small library of hybrid scaffolds of benzothiazole having hydrazone and evaluation of their β-glucuronidase activity.
    Taha M; Arbin M; Ahmat N; Imran S; Rahim F
    Bioorg Chem; 2018 Apr; 77():47-55. PubMed ID: 29331764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of indole analogs as potent β-glucuronidase inhibitors.
    Baharudin MS; Taha M; Imran S; Ismail NH; Rahim F; Javid MT; Khan KM; Ali M
    Bioorg Chem; 2017 Jun; 72():323-332. PubMed ID: 28505547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.
    Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S
    Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies.
    Khan KM; Rahim F; Wadood A; Taha M; Khan M; Naureen S; Ambreen N; Hussain S; Perveen S; Choudhary MI
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1825-9. PubMed ID: 24602903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.
    Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M
    Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel N-arylidenequinoline-3-carbohydrazides as potent β-glucuronidase inhibitors.
    Taha M; Sultan S; Nuzar HA; Rahim F; Imran S; Ismail NH; Naz H; Ullah H
    Bioorg Med Chem; 2016 Aug; 24(16):3696-704. PubMed ID: 27312423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of benzimidazole derivatives as potent β-glucuronidase inhibitors.
    Taha M; Ismail NH; Imran S; Selvaraj M; Rashwan H; Farhanah FU; Rahim F; Kesavanarayanan KS; Ali M
    Bioorg Chem; 2015 Aug; 61():36-44. PubMed ID: 26073618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Chromen-4-One-Oxadiazole Substituted Analogs as Potent
    Taha M; Rahim F; Ali M; Khan MN; Alqahtani MA; Bamarouf YA; Gollapalli M; Farooq RK; Shah SAA; Ahmed QU; Zakaria ZA
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31003424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.
    Taha M; Ismail NH; Imran S; Rashwan H; Jamil W; Ali S; Kashif SM; Rahim F; Salar U; Khan KM
    Bioorg Chem; 2016 Apr; 65():48-56. PubMed ID: 26855413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
    Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM
    Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of pyrimidine-2,4,6-trione derivatives: Anti-oxidant, anti-cancer, α-glucosidase, β-glucuronidase inhibition and their molecular docking studies.
    Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Yousuf S; Ashraf M; Shaikh NN; Iqbal Choudhary M; Khalil R; Ul-Haq Z
    Bioorg Chem; 2016 Oct; 68():72-9. PubMed ID: 27454620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidones: As novel class of β-glucuronidase inhibitors.
    Ali F; Khan KM; Salar U; Iqbal S; Taha M; Ismail NH; Perveen S; Wadood A; Ghufran M; Ali B
    Bioorg Med Chem; 2016 Aug; 24(16):3624-35. PubMed ID: 27325448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking.
    Khan KM; Rahim F; Halim SA; Taha M; Khan M; Perveen S; Zaheer-Ul-Haq ; Mesaik MA; Iqbal Choudhary M
    Bioorg Med Chem; 2011 Jul; 19(14):4286-94. PubMed ID: 21684753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studies.
    Iraji A; Nouri A; Edraki N; Pirhadi S; Khoshneviszadeh M; Khoshneviszadeh M
    Bioorg Med Chem; 2020 Apr; 28(7):115359. PubMed ID: 32098709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of oxadiazole-coupled-thiadiazole derivatives as a potent β-glucuronidase inhibitors and their molecular docking study.
    Taha M; Imran S; Alomari M; Rahim F; Wadood A; Mosaddik A; Uddin N; Gollapalli M; Alqahtani MA; Bamarouf YA
    Bioorg Med Chem; 2019 Jul; 27(14):3145-3155. PubMed ID: 31196753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted thieno[2,3-b]thiophenes and related congeners: Synthesis, β-glucuronidase inhibition activity, crystal structure, and POM analyses.
    Mabkhot YN; Barakat A; Yousuf S; Choudhary MI; Frey W; Ben Hadda T; Mubarak MS
    Bioorg Med Chem; 2014 Dec; 22(23):6715-6725. PubMed ID: 25245672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidin-2-cyanamides derivatives as novel potent
    Zhou TS; Wei B; He M; Li YS; Wang YK; Wang SJ; Chen JW; Zhang HW; Cui ZN; Wang H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1736-1742. PubMed ID: 32928007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.